Francesca Pasinelli lascia ruoli operativi ma resta in Consiglio
Risultati per: Diagnosi precoce del tumore al pancreas in medicina generale
Questo è quello che abbiamo trovato per te
Nuovo bersaglio terapeutico per il cancro al pancreas
Telethon nomina Ilaria Villa nuovo direttore generale
Francesca Pasinelli lascia i ruoli operativi, ma resta nel Consiglio
Telethon nomina Ilaria Villa nuovo direttore generale
Francesca Pasinelli lascia i ruoli operativi, ma resta nel Consiglio
Scoperto bersaglio per il trattamento del cancro al pancreas
Medicina: 81mila dottori al 2029, ma pochi vogliono fare il chirurgo o l’anestesista
Boom di laureati nei prossimi anni, ma molte specializzazioni vanno deserte perché poco attrattive per stipendi e carriera e così una borsa su tre resta vuota
A single-cell atlas of the murine pancreatic ductal tree identifies novel cell populations with potential implications in pancreas regeneration and exocrine pathogenesis.
Pancreatic ducts form an intricate network of tubules that secrete bicarbonate and drive acinar secretions into the duodenum. This network is formed by centroacinar cells, terminal, intercalated, intracalated ducts, and the main pancreatic duct. Ductal heterogeneity at the single-cell level has been poorly characterized; therefore, our understanding of the role of ductal cells in pancreas regeneration and exocrine pathogenesis has been hampered by the limited knowledge and unexplained diversity within the ductal network.
Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects against pancreatitis in mice
Objective
Currently, there is no cure for chronic pancreatitis (CP). Germline loss-of-function variants in SPINK1 (encoding trypsin inhibitor) are common in patients with CP and are associated with acute attacks and progression of the disease. This preclinical study was conducted to explore the potential of adeno-associated virus type 8 (AAV8)-mediated overexpression of human SPINK1 (hSPINK1) for pancreatitis therapy in mice.
Design
A capsid-optimised AAV8-mediated hSPINK1 expression vector (AAV8-hSPINK1) to target the pancreas was constructed. Mice were treated with AAV8-hSPINK1 by intraperitoneal injection. Pancreatic transduction efficiency and safety of AAV8-hSPINK1 were dynamically evaluated in infected mice. The effectiveness of AAV8-hSPINK1 on pancreatitis prevention and treatment was studied in three mouse models (caerulein-induced pancreatitis, pancreatic duct ligation and Spink1 c.194+2T >C mouse models).
Results
The constructed AAV8-hSPINK1 vector specifically and safely targeted the pancreas, had low organ tropism for the heart, lungs, spleen, liver and kidneys and had a high transduction efficiency (the optimal expression dose was 2×1011 vg/animal). The expression and efficacy of hSPINK1 peaked at 4 weeks after injection and remained at significant level for up to at least 8 weeks. In all three mouse models, a single dose of AAV8-hSPINK1 before disease onset significantly alleviated the severity of pancreatitis, reduced the progression of fibrosis, decreased the levels of apoptosis and autophagy in the pancreas and accelerated the pancreatitis recovery process.
Conclusion
One-time injection of AAV8-hSPINK1 safely targets the pancreas with high transduction efficiency and effectively ameliorates pancreatitis phenotypes in mice. This approach is promising for the prevention and treatment of CP.
Tumore prostata, test della saliva piu’ attendibile del PSA
Epidemiologia delle zoonosi in medicina generale
Milano, apre il Centro di Medicina aerospaziale per le terapie avanzate
Frutto dell’accordo quadro tra l’Università di Milano, l’Aeronautica Militare e la Fondazione Ca’ Granda Ospedale Maggiore Policlinico, il Cemata si propone come esempio di think-tank civile-militare
Mattarella, 'tumore al seno insidioso, diffondere la prevenzione'
‘Sarò alla partenza della race, se avessi meno anni correrei’
Diagnosi più affidabili dal matrimonio tra radiologia e IA
Con la Radiomica si può sapere se il paziente risponde a terapie
Un bimbo su 5 in un'altra regione per curare un tumore
Picchi fino al 60%. Sopravvivenza maggiore se i Centri sono vicini